Drug Information

Drug General Information
Drug ID
D07XFT
Former ID
DNC001210
Drug Name
Ribavirin-TP
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535038]
Structure
Download
2D MOL

3D MOL
Formula
C8H15N4O14P3
Canonical SMILES
C1=NC(=NN1C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)<br />C(=O)N
InChI
1S/C8H15N4O14P3/c9-6(15)7-10-2-12(11-7)8-5(14)4(13)3(24-8)1-23-28(19,20)26-29(21,22)25-27(16,17)18/h2-5,8,13-14H,1H2,(H2,9,15)(H,19,20)(H,21,22)(H2,16,17,18)/t3-,4-,5-,8-/m1/s1
InChIKey
MMJOCKKLRMRSEQ-AFCXAGJDSA-N
CAS Number
CAS 63142-71-2
PubChem Compound ID
122108
PubChem Substance ID
596738, 841292, 10239945, 15059500, 29302555, 46392531, 77070029, 103557131, 104415036, 134340241, 134340427, 135079941, 144080008, 160655148, 160849656, 164764861
Target and Pathway
Target(s) Nonstructural protein NS3 Target Info Inhibitor [535038]
References
Ref 535038ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy. Acta Biochim Pol. 2000;47(1):173-80.
Ref 535038ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy. Acta Biochim Pol. 2000;47(1):173-80.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.